Filing Details

Accession Number:
0001179110-18-001261
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-30 17:48:52
Reporting Period:
2018-01-29
Accepted Time:
2018-01-30 17:48:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1428336 Healthequity Inc HQY Services-Business Services, Nec (7389) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1614957 Ashley Dreier C/O Healthequity, Inc.
15 W. Scenic Pointe Dr., Ste. 100
Draper UT 84020
Executive, Vp, Cto And Cio No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-29 12,000 $1.50 17,652 No 4 M Direct
Common Stock Disposition 2018-01-29 12,000 $52.00 5,652 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-01-29 12,000 $0.00 12,000 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,500 2023-05-09 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $14.00 2024-07-30 3,000 3,000 Direct
Common Stock Stock Option (right to buy) $1.50 2023-05-09 100,000 100,000 Direct
Common Stock Stock Option (right to buy) $24.36 2026-03-23 65,000 65,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-07-30 3,000 3,000 Direct
2023-05-09 100,000 100,000 Direct
2026-03-23 65,000 65,000 Direct
Footnotes
  1. The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at $52.00 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each transaction as set forth in this footnote to this Form 4.
  3. The option is immediately exercisable.
  4. The option is immediately exercisable as to 16,250 shares. The option becomes exercisable as to the remaining 48,750 shares in three equal installments on March 23, 2018, 2019 and 2020.